DRUG Balance Sheet - Assets & Equity

YoY

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Total Assets

90.88M

+55.62%

84.42M

+1282.92%

52.50M

+736.23%

56.47M

+764.61%

58.40M

+747.95%

6.11M

-11.26%

6.28M

-25.8%

6.53M

-34.6%

6.89M

-40.37%

6.88M

-43.09%

8.46M

-4.07%

9.99M

-15.1%

11.55M

-25.06%

12.09M

-39.69%

8.82M

-60.3%

11.76M

-54.3%

15.41M

+602.51%

20.04M

22.21M

25.74M

2.19M

Total Current Assets

90.79M

+55.93%

84.31M

+1308.22%

52.37M

+735.79%

56.31M

+766.25%

58.22M

+751.35%

5.99M

-12.12%

6.27M

-25.19%

6.50M

-34.23%

6.84M

-40.16%

6.81M

-42.98%

8.38M

-5.01%

9.88M

-15.96%

11.43M

-25.84%

11.95M

-40.37%

8.82M

-60.3%

11.76M

-54.31%

15.41M

+603.06%

20.04M

22.21M

25.74M

2.19M

Cash & Short Term Investments

89.05M

+53.8%

82.91M

+1349.43%

51.39M

+730.14%

55.68M

+838.57%

57.90M

+756.25%

5.72M

-15.23%

6.19M

-23.86%

5.93M

-38.66%

6.76M

-39.69%

6.75M

-41.97%

8.13M

-5.9%

9.67M

-15.66%

11.21M

-25.84%

11.63M

-41.15%

8.64M

-60.74%

11.47M

-54.94%

15.12M

+616.87%

19.76M

22.01M

25.45M

2.11M

Loans & Receivables - Net

502.68K

+650.03%

413.07K

+722.46%

272.63K

+1481.77%

233.57K

-57.78%

67.02K

+48.8%

50.22K

+35.81%

17.24K

-83.38%

553.25K

+1558.27%

45.04K

-24.02%

36.98K

-76.26%

103.68K

+7.51%

33.36K

-83.99%

59.27K

-60.4%

155.78K

+41.43%

96.44K

+23.66%

208.40K

+467.14%

149.69K

+29838%

110.15K

77.98K

36.75K

500.00

Prepaid Expenses

1.24M

+379.6%

987.91K

+356.04%

708.39K

+1114.74%

401.39K

+2521.23%

257.95K

+704.31%

216.63K

+682.28%

58.32K

-58.86%

15.31K

-91.44%

32.07K

-79.72%

27.69K

-83.16%

141.74K

+76.53%

178.84K

+110.01%

158.16K

+11.26%

164.43K

-2.25%

80.29K

-37.31%

85.16K

-66.32%

142.16K

+138.61%

168.21K

128.07K

252.80K

59.58K

Total Non-Current Assets

92.18K

-47.92%

111.97K

-4.84%

128.98K

+968.12%

154.51K

+411.84%

176.99K

+266.45%

117.66K

+77.16%

12.07K

-85.71%

30.19K

-70.59%

48.30K

-60%

66.41K

-52.17%

84.53K

+4126.25%

102.64K

+5031.9%

120.75K

+5937.55%

138.86K

+6843.15%

2.00K

Property Plant & Equipment - Net

92.18K

-47.92%

111.97K

-4.84%

128.98K

+968.12%

154.51K

+411.84%

176.99K

+266.45%

117.66K

+77.16%

12.07K

-85.71%

30.19K

-70.59%

48.30K

-60%

66.41K

-52.17%

84.53K

102.64K

120.75K

138.86K

Intangible Assets - Net

-100%

0.00

-100%

2.00K

Total Liabilities

1.60M

+179.8%

2.38M

+318.23%

667.83K

+273.87%

726.81K

-14.07%

571.59K

-33.08%

568.26K

+102.33%

178.63K

-75.69%

845.79K

-18.71%

854.16K

+46.6%

280.86K

-81.82%

734.81K

+90.7%

1.04M

+3.69%

582.66K

+19.01%

1.54M

+141.86%

385.32K

+19.35%

1.00M

+145.22%

489.60K

+245.83%

638.57K

322.86K

409.24K

141.57K

Total Current Liabilities

1.58M

+242.9%

2.33M

+341.73%

604.99K

+238.69%

637.97K

-24.57%

461.52K

-45.97%

528.68K

+88.24%

178.63K

-75.22%

845.79K

-15.91%

854.16K

+61.74%

280.86K

-80.93%

720.80K

+87.06%

1.01M

+0.23%

528.10K

+7.86%

1.47M

+130.59%

385.32K

+19.35%

1.00M

+145.22%

489.60K

+245.83%

638.57K

322.86K

409.24K

141.57K

Accounts Payable & Accruals

1.49M

+284.31%

2.25M

+400.97%

526.80K

+220.03%

560.22K

-30.93%

388.86K

-51.37%

449.30K

+116.73%

164.61K

-74.42%

811.05K

-13%

799.60K

+74.52%

207.31K

-85.24%

643.40K

+66.98%

932.20K

-7.11%

458.18K

-6.42%

1.41M

+119.95%

385.32K

+19.35%

1.00M

+145.22%

489.60K

+312.48%

638.57K

322.86K

409.24K

118.70K

Short-Term Debt & Current Portion of Long-Term Debt

88.16K

+21.32%

84.53K

+6.48%

78.19K

+457.85%

77.75K

+123.86%

72.67K

+33.18%

79.38K

+7.93%

14.02K

-81.89%

34.73K

-52.8%

54.56K

-21.96%

73.55K

+8.27%

77.39K

73.59K

69.91K

67.93K

Total Non-Current Liabilities

16.74K

-84.79%

41.25K

+4.23%

62.84K

88.85K

110.07K

39.58K

-100%

0.00

-100%

0.00

-100%

14.02K

34.73K

54.56K

71.98K

Debt - Long-Term

16.74K

-84.79%

41.25K

+4.23%

62.84K

88.85K

110.07K

39.58K

-100%

0.00

-100%

0.00

-100%

14.02K

34.73K

54.56K

71.98K

Total Shareholders' Equity

89.28M

+54.39%

82.05M

+1381.93%

51.83M

+749.77%

55.74M

+880.45%

57.83M

+858.53%

5.54M

-16.09%

6.10M

-21.05%

5.68M

-36.45%

6.03M

-44.99%

6.60M

-37.41%

7.73M

-8.4%

8.95M

-16.85%

10.97M

-26.51%

10.54M

-45.66%

8.43M

-61.47%

10.76M

-57.52%

14.92M

+627.11%

19.40M

21.89M

25.33M

2.05M

Shareholders' Equity

89.28M

+54.39%

82.05M

+1381.93%

51.83M

+749.77%

55.74M

+880.45%

57.83M

+858.53%

5.54M

-16.09%

6.10M

-21.05%

5.68M

-36.45%

6.03M

-44.99%

6.60M

-37.41%

7.73M

-8.4%

8.95M

-16.85%

10.97M

-26.51%

10.54M

-45.66%

8.43M

-61.47%

10.76M

-57.52%

14.92M

+627.11%

19.40M

21.89M

25.33M

2.05M

Common Equity Attributable to Parent Shareholders

89.28M

+54.39%

82.05M

+1381.93%

51.83M

+749.77%

55.74M

+880.45%

57.83M

+858.53%

5.54M

-16.09%

6.10M

-21.05%

5.68M

-36.45%

6.03M

-44.99%

6.60M

-37.41%

7.73M

-8.4%

8.95M

-16.85%

10.97M

-26.51%

10.54M

-45.66%

8.43M

-61.47%

10.76M

-57.52%

14.92M

+627.11%

19.40M

21.89M

25.33M

2.05M

Total Liabilities & Equity

90.88M

+55.62%

84.42M

+1282.92%

52.50M

+736.23%

56.47M

+764.61%

58.40M

+747.95%

6.11M

-11.26%

6.28M

-25.8%

6.53M

-34.6%

6.89M

-40.37%

6.88M

-43.09%

8.46M

-4.07%

9.99M

-15.1%

11.55M

-25.06%

12.09M

-39.69%

8.82M

-60.3%

11.76M

-54.3%

15.41M

+602.51%

20.04M

22.21M

25.74M

2.19M

Net Debt

-88.94M

+54.11%

-82.78M

+1377.97%

-51.25M

+729.74%

-55.51M

+841.27%

-57.71M

+760.49%

-5.60M

-16.08%

-6.18M

-23.17%

-5.90M

-38.33%

-6.71M

-39.51%

-6.67M

-41.9%

-8.04M

-6.96%

-9.56M

-16.6%

-11.09M

-26.67%

-11.49M

-41.86%

-8.64M

-60.74%

-11.47M

-54.94%

-15.12M

+616.87%

-19.76M

-22.01M

-25.45M

-2.11M

Working Capital

89.20M

+54.44%

81.97M

+1401.84%

51.76M

+750.37%

55.68M

+884.52%

57.76M

+865.15%

5.46M

-16.44%

6.09M

-20.48%

5.66M

-36.3%

5.99M

-45.1%

6.53M

-37.65%

7.66M

-9.21%

8.88M

-17.47%

10.90M

-26.94%

10.48M

-46%

8.43M

-61.48%

10.76M

-57.53%

14.92M

+627.72%

19.40M

21.89M

25.33M

2.05M

DRUG Financials

DRUG Financials

Summary

Key Indicators

Income Statement

Balance Sheet

Cash Flow